Related Experiment Video
Updated: May 19, 2026

12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Multiparameter flow cytometry and bioanalytics for B cell profiling in systemic lupus erythematosus
Denise A Kaminski1, Chungwen Wei, Alexander F Rosenberg
1Division of Allergy, Immunology, and Rheumatology, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Methods in Molecular Biology (Clifton, N.J.)
|August 31, 2012
Summary
Researchers are characterizing B cell subsets in lupus to identify disease signatures. This approach may improve diagnosis, prognosis, and treatment for autoimmune diseases.
Area of Science:
- Immunology
- Autoimmunity
- Flow Cytometry
Background:
- B lymphocytes are key players in systemic lupus erythematosus (SLE), primarily known for autoantibody production.
- Distinct B cell subsets exhibit unique antibody-dependent and independent functions.
- Understanding these subsets is crucial for advancing autoimmunity research.
Purpose of the Study:
- To develop and apply specialized B cell reagent panels for multiparameter flow cytometry.
- To utilize advanced bioinformatics strategies for comprehensive B cell subset analysis.
- To establish B cell signatures linked to disease severity, progression, and treatment response in lupus.
Main Methods:
- Development of specialized B cell reagent panels for multiparameter flow cytometry.
- Application of advanced bioinformatics for analyzing complex B cell data.
- Characterization of distinct human B cell subsets in the context of chronic inflammatory diseases.
Main Results:
- Identification of distinct B cell subpopulations with specific effector functions.
- Establishment of a methodology combining flow cytometry and bioinformatics for B cell subset characterization.
- Potential for discovering B cell signatures correlating with disease phenotypes.
Conclusions:
- Characterizing human B cell subsets offers a pathway to improved understanding of lupus pathogenesis.
- This approach holds promise for enhancing disease characterization, prognosis, and treatment strategies.
- The developed methodology can be applied to other chronic inflammatory diseases.

